Mizuho raised the firm’s price target on Herbalife (HLF) to $9 from $8 and keeps a Neutral rating on the shares. The company’s Q3 adjusted EBITDA beat on benefits from savings while global volume points remained soft, the analyst tells investors in a research note.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.